CELLECTAR BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.33 USD | -2.63% |
|
+7.42% | +20.22% |
Chart calendar Cellectar Biosciences, Inc.
4222e2.JSk-pyDl4ismw6kTS4yFS_lqphXvNm5q7Q1qNMwbtAQ.V1BmwXW00BJIkOFUeOG0HKAJ1XKEYRYBjHwrZqJ-3n4dbwuSVIrSWQuGmQ~033ac759c0e77e6a8d21eb9559fd8ef7
Upcoming events on Cellectar Biosciences, Inc.
Past events on Cellectar Biosciences, Inc.
| Today | Q1 2024 Earnings Release (Projected) |
| 2024-03-27 08:30 am | Q4 2023 Earnings Call |
| 2024-03-27 06:40 am | Q4 2023 Earnings Release |
| 2024-03-19 12:00 pm | Roth Conference |
| 2024-03-19 12:00 pm | Roth Conference |
| 2024-02-14 02:00 pm | Oppenheimer Healthcare Life Sciences Conference |
| 2024-01-19 08:30 am | Investor Meeting - Key Opinion Leader |
| 2024-01-09 05:00 pm | Biotech Showcase |
| 2024-01-08 08:00 am | Iopofosine I 131 Trial Results Call |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2023-12-07 05:30 am | Targeted Radiopharmaceuticals Summit |
| 2023-11-02 08:30 am | Q3 2023 Earnings Call |
| 2023-11-02 07:30 am | Q3 2023 Earnings Release |
| 2023-10-25 10:00 am | Extraordinary Shareholders Meeting |
| 2023-08-14 08:40 am | Q2 2023 Earnings Release |
| 2023-06-25 | Society of Nuclear Medicine and Molecular Imaging Meeting - Abstract No #P1243 |
| 2023-06-23 10:00 am | Annual General Meeting |
| 2023-05-04 08:40 am | Q1 2023 Earnings Release |
| 2023-03-14 10:00 am | Oppenheimer Healthcare Conference |
| 2023-03-13 11:30 am | Roth Capital Partners Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,2 -14,3 0.77% | -15,3 -15,8 3.16% | -24,1 -24,5 1.5% | -28,8 -29,7 3.12% | -39,0 -35,4 -9.93% | -49,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,1 -14,1 0.08% | -15,1 -15,7 3.8% | -24,1 -24,5 1.49% | -28,7 -29,7 3.4% | -38,0 -40,0 4.97% | -46,6 |
|
Net income Million USD | Released Forecast Spread | -14,1 -14,2 0.63% | -15,1 -15,7 3.91% | -24,1 -24,5 1.4% | -28,6 -29,7 3.81% | -38,0 -36,3 -4.5% | -49,0 |
|
EPS USD | Released Forecast Spread | -18,4 -18,9 2.77% | -7,60 -8,20 7.32% | -4,30 -4,43 2.82% | -4,05 -3,31 -22.54% | -3,11 -2,62 -18.59% | -1,63 |
| Announcement Date | 09/03/20 | 02/03/21 | 21/03/22 | 09/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,92 -6,29 5.86% | -6,14 -6,38 3.72% | -7,44 -6,36 -16.95% | -7,82 -7,72 -1.25% | -7,42 -8,35 11.11% | -8,71 -7,64 -13.92% | -8,29 -7,81 -6.19% | -9,41 -8,53 -10.31% | -12,5 -9,47 -32.46% | -13,3 | -12,7 | -12,6 | -13,4 | -17,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,92 -6,28 5.8% | -6,14 -6,15 0.15% | -7,44 -6,24 -19.11% | -7,81 -7,38 -5.91% | -7,28 -8,29 12.19% | -8,58 -8,06 -6.53% | -8,22 -8,37 1.77% | -13,7 -9,12 -50.52% | -7,51 -9,50 20.94% | -12,8 | -13,1 | -13,4 | -14,0 | |
|
Net income Million USD | Released Forecast Spread | -5,92 -6,26 5.49% | -6,14 -6,38 3.72% | -7,44 -6,36 -16.94% | -7,81 -7,66 -1.92% | -7,22 -8,35 13.54% | -8,58 -7,64 -12.34% | -8,22 -7,80 -5.47% | -13,7 -8,53 -60.92% | -7,45 -9,24 19.38% | -13,3 | -12,7 | -12,6 | -13,4 | -17,5 |
|
EPS USD | Released Forecast Spread | -0,90 -1,03 12.2% | -1,00 -1,00 0% | -1,22 -1,04 -17.87% | -1,28 -1,26 -1.86% | -0,55 -1,08 48.84% | -0,76 -0,87 12.39% | -0,73 -0,67 -9.77% | -1,21 -0,45 -171.91% | -0,40 -0,53 24.53% | -0,56 | -0,45 | -0,43 | -0,42 | -0,50 |
| Announcement Date | 21/03/22 | 10/05/22 | 05/08/22 | 03/11/22 | 09/03/23 | 04/05/23 | 14/08/23 | 13/11/23 | 27/03/24 | - | - | - | - | - |
| 2024-05-06 | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q4 2024 Earnings Release (Projected) |
| 2024-05-06 | EVOLUS, INC.: Q1 2024 Earnings Release |
| 2024-05-06 | DR. REDDY'S LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-06 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-06 | BLAU FARMACÊUTICA S.A.: Q1 2024 Earnings Release |
| 2024-05-07 06:30 am | PERRIGO COMPANY PLC: Q1 2024 Earnings Release |
| 2024-05-07 04:00 pm | OCULAR THERAPEUTIX, INC.: Q1 2024 Earnings Release |
| 2024-05-07 04:01 pm | LIGAND PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
| 2024-05-07 04:05 pm | SIGA TECHNOLOGIES, INC.: Q1 2024 Earnings Release |
| 2024-05-07 | IMMUNOCORE HOLDINGS PLC: Q1 2024 Earnings Release (Projected) |
Past sector events for Cellectar Biosciences, Inc.
| Today | GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI: Q1 2024 Earnings Release (Projected) |
| Today | PLIANT THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| Today | LUPIN LIMITED: Q4 2024 Earnings Release |
| Today | DRI HEALTHCARE TRUST: Q1 2024 Earnings Release |
| 2024-05-03 07:07 am | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 2024-05-03 06:00 am | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-02 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
| 2024-05-02 04:01 pm | AMGEN INC.: Q1 2024 Earnings Release |
| 2024-05-02 01:43 pm | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CLRB Stock
- Calendar Cellectar Biosciences, Inc.